BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2005
View Archived Issues
New data on the benefits of APC-8015 in prostate cancer
Read More
AZD-3409 inhibits proliferation and invasion in prostate epithelial cells
Read More
Isoliquiritigenin downregulates androgen-receptor and PSA proteins
Read More
MediciNova opens phase I study for MN-221
Read More
Phase I study of Acrux transdermal spray to prevent nausea in cancer patients
Read More
Repligen enters into development agreement for uridine for bipolar disorder
Read More
Efficacy of MIV-310 in phase II HIV trial does not warrant further development
Read More
Prana begins phase I trial for PBT-2
Read More
IND accepted for clinical testing of Moli-1901 for dry eye syndrome
Read More
FDA rejects Public Citizen's petition for Crestor
Read More
Phase II study of GCAN-101 set to begin in Israel
Read More
Shionogi & Co. initiate phase I Japanese studies for Enanta antibiotic
Read More
Dainippon obtains development and marketing rights for KGA-2727 in Japan
Read More
Acyl-CoA: cholesterol acyltransferase inhibition in the treatment of Alzheimer's disease
Read More
L-791515 shows efficacy as an analgesic for postoperative dental pain
Read More
TC-1827, a nicotinic acetylcholine receptor agonist improves cognitive function
Read More
Drug-drug interactions with clopidogrel and St. John's wort
Read More
Potent and selective mGluR5 antagonist shows good PK profile
Read More
Preclinical evidence for the cognitive-enhancing effects of ZSET-1446
Read More
New agents for antiinflammatory disorders described in patent literature
Read More
Lilly scientists report the discovery of novel tachykinin NK1 receptor antagonists
Read More
Oxytocin antagonists from GlaxoSmithKline reported in patent literature
Read More
Orion reports a novel series of SARMs
Read More
Temodar approved for newly diagnosed GBM
Read More
FDA places clinical hold on studies with alpha4 integrin antagonists
Read More
FDA approves Mycamine
Read More
Symlin receives FDA approval
Read More